Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he will take to avoid regional variations in patient access to (a) radioligand therapy and (b) other specialised radiotherapy services, once specialised commissioning responsibility is delegated to integrated care boards in April 2023.

NHS England is currently the accountable and responsible commissioner for prescribed specialised services, which includes a range of cancer treatments. Following delegation to local systems, NHS England will remain the accountable commissioner for these services and maintain its role in setting national standards and holding systems to account.